Novel role of NPY in neuroimmune interaction and lung growth after intrauterine growth restriction
Standard
Novel role of NPY in neuroimmune interaction and lung growth after intrauterine growth restriction. / Thangaratnarajah, Chansutha; Dinger, Katharina; Vohlen, Christina; Klaudt, Christian; Nawabi, Jawed; Lopez Garcia, Eva; Kwapiszewska, Grazyna; Dobner, Julia; Nüsken, Kai D; van Koningsbruggen-Rietschel, Silke; von Hörsten, Stephan; Dötsch, Jörg; Alejandre Alcázar, Miguel A.
in: AM J PHYSIOL-LUNG C, Jahrgang 313, Nr. 3, 01.09.2017, S. L491-L506.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Novel role of NPY in neuroimmune interaction and lung growth after intrauterine growth restriction
AU - Thangaratnarajah, Chansutha
AU - Dinger, Katharina
AU - Vohlen, Christina
AU - Klaudt, Christian
AU - Nawabi, Jawed
AU - Lopez Garcia, Eva
AU - Kwapiszewska, Grazyna
AU - Dobner, Julia
AU - Nüsken, Kai D
AU - van Koningsbruggen-Rietschel, Silke
AU - von Hörsten, Stephan
AU - Dötsch, Jörg
AU - Alejandre Alcázar, Miguel A
N1 - Copyright © 2017 the American Physiological Society.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Individuals with intrauterine growth restriction (IUGR) are at risk for chronic lung disease. Using a rat model, we showed in our previous studies that altered lung structure is related to IL-6/STAT3 signaling. As neuropeptide Y (NPY), a coneurotransmitter of the sympathetic nervous system, regulates proliferation and immune response, we hypothesized that dysregulated NPY after IUGR is linked to IL-6, impaired myofibroblast function, and alveolar growth. IUGR was induced in rats by isocaloric low-protein diet; lungs were analyzed on embryonic day (E) 21, postnatal day (P) 3, P12, and P23. Finally, primary neonatal lung myofibroblasts (pnF) and murine embryonic fibroblasts (MEF) were used to assess proliferation, apoptosis, migration, and IL-6 expression. At E21, NPY and IL-6 expression was decreased, and AKT/PKC and STAT3/AMPKα signaling was reduced. Early reduction of NPY/IL-6 was associated with increased chord length in lungs after IUGR at P3, indicating reduced alveolar formation. At P23, however, IUGR rats exhibited a catch-up of body weight and alveolar growth coupled with more proliferating myofibroblasts. These structural findings after IUGR were linked to activated NPY/PKC, IL-6/AMPKα signaling. Complementary, IUGR-pnF showed increased survival, impaired migration, and reduced IL-6 compared with control-pnF (Co-pnF). In contrast, NPY induced proliferation, migration, and increased IL-6 synthesis in fibroblasts. Additionally, NPY-/-mice showed reduced IL-6 signaling and less proliferation of lung fibroblasts. Our study presents a novel role of NPY during alveolarization: NPY regulates1) IL-6 and lung STAT3/AMPKα signaling, and2) proliferation and migration of myofibroblasts. These new insights in pulmonary neuroimmune interaction offer potential strategies to enable lung growth.
AB - Individuals with intrauterine growth restriction (IUGR) are at risk for chronic lung disease. Using a rat model, we showed in our previous studies that altered lung structure is related to IL-6/STAT3 signaling. As neuropeptide Y (NPY), a coneurotransmitter of the sympathetic nervous system, regulates proliferation and immune response, we hypothesized that dysregulated NPY after IUGR is linked to IL-6, impaired myofibroblast function, and alveolar growth. IUGR was induced in rats by isocaloric low-protein diet; lungs were analyzed on embryonic day (E) 21, postnatal day (P) 3, P12, and P23. Finally, primary neonatal lung myofibroblasts (pnF) and murine embryonic fibroblasts (MEF) were used to assess proliferation, apoptosis, migration, and IL-6 expression. At E21, NPY and IL-6 expression was decreased, and AKT/PKC and STAT3/AMPKα signaling was reduced. Early reduction of NPY/IL-6 was associated with increased chord length in lungs after IUGR at P3, indicating reduced alveolar formation. At P23, however, IUGR rats exhibited a catch-up of body weight and alveolar growth coupled with more proliferating myofibroblasts. These structural findings after IUGR were linked to activated NPY/PKC, IL-6/AMPKα signaling. Complementary, IUGR-pnF showed increased survival, impaired migration, and reduced IL-6 compared with control-pnF (Co-pnF). In contrast, NPY induced proliferation, migration, and increased IL-6 synthesis in fibroblasts. Additionally, NPY-/-mice showed reduced IL-6 signaling and less proliferation of lung fibroblasts. Our study presents a novel role of NPY during alveolarization: NPY regulates1) IL-6 and lung STAT3/AMPKα signaling, and2) proliferation and migration of myofibroblasts. These new insights in pulmonary neuroimmune interaction offer potential strategies to enable lung growth.
KW - Adenylate Kinase
KW - Animals
KW - Animals, Newborn
KW - Apoptosis
KW - Biomarkers
KW - Cell Movement
KW - Cell Proliferation
KW - Cell Survival
KW - Diet
KW - Fetal Growth Retardation
KW - Gene Expression Regulation
KW - Interleukin-6
KW - Lung
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Models, Biological
KW - Myofibroblasts
KW - Neuropeptide Y
KW - Neurotransmitter Agents
KW - Protein Kinase C
KW - Rats, Wistar
KW - Receptors, Neuropeptide Y
KW - STAT3 Transcription Factor
KW - Signal Transduction
KW - Suppressor of Cytokine Signaling 3 Protein
KW - Sympathetic Nervous System
KW - Weight Gain
KW - Journal Article
U2 - 10.1152/ajplung.00432.2016
DO - 10.1152/ajplung.00432.2016
M3 - SCORING: Journal article
C2 - 28572154
VL - 313
SP - L491-L506
IS - 3
ER -